| The evaluation of microvessel density in rat prostate tissues treated with finasteride, bicalutamide and surgical castration | C. KAYA,M. ÖZYÜREK,L. TÜRKERİ | 365–369 |
| Development of the urinary bladder epithelium of the rat: Histochemical study | Y. ERSOY,F. ERCAN,Ş. ÇETİNEL | 370–377 |
| The protective effect of angiotensin II and calcium channel blockade on ESWL induced renal tubulointerstitial fibrosis | İ. KESGİN,H. VURUŞKAN,B. OKTAY,İ. YAVAŞÇAOĞLU,Ü. ŞİMŞEK,M. ÖZYURT | 378–382 |
| The relationship between human leucocyte antigens and renal cell carcinoma | A. ÇEKMEN,E. AKKUŞ,B. ÖNAL,E. YILMAZ,A. U. ÖZALP,V. SOLOK | 383–389 |
| Analytical and clinical evaluation of a new urinary tumor marker "Bladder Tumor Fibronectin" (BTF) in diagnosis and follow-up of bladder cancer | N. MUTLU,L. TÜRKERİ,K. EMERK | 390–396 |
| The relation of nuclear matrix protein (NMP 22) with diagnosis of bladder cancer; stage, grade, size and number of the tumor and comparision the findings with cytology | Ö. SARILAR,E. MERDER,Ş. KABAY,M. BİNBAY,Y. BERBEROĞLU,A. Y. MÜSLÜMANOĞLU | 397–400 |
| The incidence of bacteriuria before intravesical immunotheraphy applications | O. EKMEKÇİOĞLU,A. TATLIŞEN,D. DEMİRCİ,E. KEKLİK | 401–405 |
| Efficiency of TIPU technique on distal hypospadias | T. ÇAŞKURLU,F. YILDIZ,M. İ. KARAMAN,C. SÖNMEZ,S. GÜNEY,E. ERGENEKON | 406–410 |
| Prepuce and bacterial colonization | S. RESİM,P. ÇIRAGİL,A. İ. TAŞÇI | 411–415 |
| Aspiration and sclerotherapy with 3% polidocanol for hydrocele treatment | A. S. GÖZEN,B. ALAGÖL,İ. H. ATAKAN | 416–421 |
| Our experience of percutaneous nephrolithotomy in the first 50 renal units | A. ÜNSAL,E. ÇİMENTEPE,R. SAĞLAM | 422–427 |
| Recurrent urinary stone disease: Evaluation of epidemiological risk factors | C. ADAYENER,C. İŞERİ,T. ŞENKUL,K. KARADEMİR,K. BAYKAL,D. ERDEN | 428–436 |
| İnternational prostate symptom score, prostate volum and uroflowmetry in patients with lower urinary tract symptoms |